A New Immunotherapy for Bladder Cancer
A New Immunotherapy for Bladder Cancer
Dec 29, 2019
aacr.org
The FDA has expanded its approval of Imfinzi® (durvalumab), to include stage III non-small cell lung cancer patients. The immunotherapy was approved for bladder cancer last year, but Moffitt’s Dr. Scott Antonia saw the potential of Imfinzi as a treatment option for lung cancer patients. He launched a global clinical trial with more than 700 patients and found the therapy made a big difference in survival for this group of patients. http://ow.ly/bwij30ivPPd | Moffitt Cancer Center
0:34
The FDA has expanded its approval of Imfinzi® (durvalumab), to includ…
4.8K viewsFeb 20, 2018
FacebookMoffitt Cancer Center
FDA Approval of Durvalumab for Advanced Bladder Cancer | OncLive
FDA Approval of Durvalumab for Advanced Bladder Cancer | OncLive
Apr 22, 2017
onclive.com
DUO-E Trial: Durvalumab With or Without Olaparib for Endometrial Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
DUO-E Trial: Durvalumab With or Without Olaparib for Endometrial …
Jan 6, 2022
targetedonc.com
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab Study in Urothelial Carcinoma | OncLive
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab S…
Feb 10, 2018
onclive.com
The Use of Durvalumab in Locally Advanced NSCLC
3:07
The Use of Durvalumab in Locally Advanced NSCLC
292 viewsApr 16, 2018
YouTubeTargeted Oncology
Effectively Managing Treatment With Durvalumab
5:13
Effectively Managing Treatment With Durvalumab
483 viewsJun 25, 2018
YouTubeTargeted Oncology
Durvalumab: A Review in Extensive-Stage SCLC
Jan 27, 2020
nih.gov
Durvalumab Tolerability in Non–Small Cell Lung Cancer
1.5K viewsFeb 25, 2020
YouTubeTargeted Oncology
2:43
FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small …
3.7K viewsSep 12, 2024
YouTubeOncologyTube
6:07
PACIFIC Trial: Durvalumab Following Chemotherapy for Stag…
3K viewsJul 13, 2020
YouTubeOncLive
2:31
Durvalumab plus tremelimumab or durvalumab monotherapy in meta…
212 viewsFeb 14, 2018
YouTubeecancer
0:08
GO2 for Lung Cancer on Instagram: "📢 The @fda has approved Imfinzi (…
586 viewsDec 6, 2024
Instagramgo2forlungcancer
52:55
Immunotherapy Nightmare - Imfinzi/Durvalumab Experience - L…
406.1K viewsSep 18, 2022
YouTubeThe Apples
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carci…
219 viewsJun 6, 2022
nejm.org
1:17
The impact of durvalumab on the SCLC treatment landscape
386 views1 year ago
YouTubeVJOncology
1:18
Gastric Cancer Immunotherapy: Matterhorn Trial Durvalumab Resu…
325 views9 months ago
YouTubeOncologyTube
2:03
Durvalumab FDA Approval for Bladder Cancer
219 viewsMay 5, 2017
YouTubeOncLive
2:15
The impact of durvalumab for resectable non-small cell lung can…
552 viewsSep 26, 2024
YouTubeVJOncology
When to Initiate Consolidation Durvalumab
Aug 30, 2021
medscape.com
7:44
Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of C…
3K viewsFeb 20, 2018
YouTubeBeaconMedIC
What Is Immunotherapy? | Cancer Research Institute
7 months ago
cancerresearch.org
10:01
IMFINZI®: A Breakthrough in Early-Stage Gastric Cancer Treatment
4 months ago
YouTubeVision Place
30:24
NIAGARA - New Standard for Muscle Invasive Bladder Cancer w…
3.9K views9 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discus…
7:48
HIMALAYA: Study of tremelimumab and durvalumab as first-line thera…
1.2K viewsMar 21, 2022
YouTubeecancer
Dr. Joshi on Durvalumab/RT Combo in Locally Advanced Urothelial Ca…
Feb 28, 2020
onclive.com
1:37
Results for Durvalumab in the Second-Line Treatment of NSCLC
542 viewsJul 13, 2017
YouTubeTargeted Oncology
1:22
Evaluating durvalumab and chemotherapy for MIBC in the NIA…
69 views4 months ago
YouTubeVJOncology
6:04
Durvalumab plus chemotherapy significantly improved OS in adva…
1.5K viewsMar 21, 2022
YouTubeecancer
9:49
NIAGARA Trial - Periop Durvalumab with Neoad Chemo Resectable Mu…
752 viewsOct 12, 2024
YouTubeOncUpdates: Latest Oncology Insights
See more videos
Static thumbnail place holder